Search research articles
Contact Us
Filters
Showing results (91-100 of 101) with videos related to
Page
of 11
Sort By:
Cancer Treatment Reports
|
March 1, 1978
Yoshi 864 (1-propanol, 3,3'-iminodi-, dimethanesulfonate [ester], hydrochloride): a phase II study in solid tumors
S J Altman, G E Metter, T F Nealon, et al.
The Cancer Journal From Scientific American
|
April 3, 1999
A phase II evaluation of all-trans-retinoic acid plus interferon alfa-2a in stage IV melanoma: a Southwest Oncology Group study
V K Sondak, P Y Liu, L E Flaherty, et al.
Cancer Treatment Reports
|
May 1, 1976
DTIC (nsc-45388) and combination therapy for melanoma. I. Studies with DTIC, BCNU (NSC-409962), CCNU (NSC-79037), vincristine (NSC-67574), and hydroxyurea (NSC-32065)
R D Carter, E T Krementz, G J Hill, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 1, 1986
Effect of alternating combination chemotherapy on survival of ambulatory patients with metastatic large-cell and adenocarcinoma of the lung. A Southwest Oncology Group Study
T P Miller, T T Chen, C A Coltman, et al.
Cancer
|
March 15, 1985
Results of a 400-patient carcinoembryonic antigen second-look colorectal cancer study
J P Minton, J L Hoehn, D M Gerber, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 17, 1998
Southwest Oncology Group phase II trial of concurrent carboplatin, etoposide, and radiation for poor-risk stage III non-small-cell lung cancer
D H Lau, J J Crowley, D R Gandara, et al.
Cancer Treatment Reports
|
September 1, 1986
Randomized comparisons of radiotherapy and carmustine versus procarbazine versus dacarbazine for the treatment of malignant gliomas following surgery: a Southwest Oncology Group Study
H J Eyre, J R Eltringham, E A Gehan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 1, 1994
Randomized trial of vitamin A versus observation as adjuvant therapy in high-risk primary malignant melanoma: a Southwest Oncology Group study
F L Meyskens, P Y Liu, R J Tuthill, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 20, 1998
Phase II study of carmustine, dacarbazine, cisplatin, and tamoxifen in advanced melanoma: a Southwest Oncology Group study
K A Margolin, P Y Liu, L E Flaherty, et al.
Journal of Cancer Research and Clinical Oncology
|
June 8, 1999
Phase II trial of biochemotherapy with interferon alpha, dacarbazine, cisplatin and tamoxifen in metastatic melanoma: a Southwest Oncology Group trial
K A Margolin, P Y Liu, J M Unger, et al.
Page
of 11
Search research articles
Search
Showing results (91-100 of 101) with videos related to
Sort By:
Page
of 11
Cancer Treatment Reports
|
March 1, 1978
Yoshi 864 (1-propanol, 3,3'-iminodi-, dimethanesulfonate [ester], hydrochloride): a phase II study in solid tumors
S J Altman, G E Metter, T F Nealon, et al.
The Cancer Journal From Scientific American
|
April 3, 1999
A phase II evaluation of all-trans-retinoic acid plus interferon alfa-2a in stage IV melanoma: a Southwest Oncology Group study
V K Sondak, P Y Liu, L E Flaherty, et al.
Cancer Treatment Reports
|
May 1, 1976
DTIC (nsc-45388) and combination therapy for melanoma. I. Studies with DTIC, BCNU (NSC-409962), CCNU (NSC-79037), vincristine (NSC-67574), and hydroxyurea (NSC-32065)
R D Carter, E T Krementz, G J Hill, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 1, 1986
Effect of alternating combination chemotherapy on survival of ambulatory patients with metastatic large-cell and adenocarcinoma of the lung. A Southwest Oncology Group Study
T P Miller, T T Chen, C A Coltman, et al.
Cancer
|
March 15, 1985
Results of a 400-patient carcinoembryonic antigen second-look colorectal cancer study
J P Minton, J L Hoehn, D M Gerber, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 17, 1998
Southwest Oncology Group phase II trial of concurrent carboplatin, etoposide, and radiation for poor-risk stage III non-small-cell lung cancer
D H Lau, J J Crowley, D R Gandara, et al.
Cancer Treatment Reports
|
September 1, 1986
Randomized comparisons of radiotherapy and carmustine versus procarbazine versus dacarbazine for the treatment of malignant gliomas following surgery: a Southwest Oncology Group Study
H J Eyre, J R Eltringham, E A Gehan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 1, 1994
Randomized trial of vitamin A versus observation as adjuvant therapy in high-risk primary malignant melanoma: a Southwest Oncology Group study
F L Meyskens, P Y Liu, R J Tuthill, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 20, 1998
Phase II study of carmustine, dacarbazine, cisplatin, and tamoxifen in advanced melanoma: a Southwest Oncology Group study
K A Margolin, P Y Liu, L E Flaherty, et al.
Journal of Cancer Research and Clinical Oncology
|
June 8, 1999
Phase II trial of biochemotherapy with interferon alpha, dacarbazine, cisplatin and tamoxifen in metastatic melanoma: a Southwest Oncology Group trial
K A Margolin, P Y Liu, J M Unger, et al.
Page
of 11